Clinical Trial

Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40

Not Yet Recruiting

Record status

This record was last updated September 5, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

This study will look at how well a measure called the Qmax/eGFR ratio is related to the severity of urination problems in men over the age of 40. Qmax is a test that shows how fast a person can urinate, and eGFR is a number that reflects kidney function. Men who have urinary symptoms will be asked to do a urine flow test, a blood test, and fill out a questionnaire about their symptoms and quality of life. We will study if there is a link between the Qmax/eGFR ratio and how severe their symptoms are. The results may help doctors better understand how kidney and urinary function are related in men with these problems.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-29.

Trial Details

NCT Number	NCT07055425
Lead Sponsor	Marmara University
Conditions	Lower Urinary Tract Symptom, Voiding Dysfunction, Male Urological Health, Renal Function, Benign Prostate Obstruction (BPO)
Enrollment	100 participants
Start Date	2025-09-01
Primary Completion	2026-01-01 (estimated)
Study Completion	2026-05-01 (estimated)
Updated on ClinicalTrials.gov	2025-09-05